ArticleArchives of rehabilitation research and clinical translation2025
Barriers to Mobility in the ICU: Insights from Severe COVID-19 and Implications for Improving Patient Outcomes.
Article in Archives of rehabilitation research and clinical translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate mobility outcomes of patients with severe COVID-19 during their intensive care unit (ICU) stay compared to non-COVID-19 critically ill counterparts and assess factors impacting mobility status. Design: A retrospective, single-center case-control study. Setting: This investigation was conducted at a large tertiary care center at the epicenter of the COVID-19 pandemic between April 2019 and July 2020 to capture a prepandemic baseline and the initial surge. Participants: A total of 3275 ICU cases were analyzed. Analysis was conducted at the ICU visit level rather than the patient level. Eligible visits included adults ≥18 years. The COVID-19 cohort (COVID vs non-COVID) was defined by confirmed infection (polymerase chain reaction or equivalent testing). ICU visits with missing data were excluded and subsequently matched via coarsened exact matching. Interventions: Not applicable. Main Outcome Measures: Primary outcome measure was an ICU visit's highest ICU mobility status (Immobile, Nonambulatory, Ambulatory) at any time during their stay. Secondary outcomes included age, sex, body mass index, APACHE-III score, Richmond Agitation Sedation Scale, patient expired, tracheostomy status, percutaneous endoscopic gastrostomy status, hospital length of stay, prone status, and physical therapy status. Results: The COVID visits were overwhelmingly categorized as immobile, whereas non-COVID visits were more likely to be ambulatory. Multinomial regression showed that COVID patients were 60% less likely to be Nonambulatory and 93% less likely to be Ambulatory versus immobile. COVID-19 visits were also associated with higher final APACHE-III scores ( Conclusions: Severe COVID-19 significantly affects ICU mobility, with COVID visits experiencing reduced mobility compared to non-COVID visits. These findings underscore the urgent need for innovative sedation protocols and ICU mobilization strategies to mitigate risks of ICU-acquired weakness, postintensive care syndrome, and other long-term disabilities. Addressing these challenges is critical to improving outcomes for all ICU patients facing barriers to traditional mobilization strategies and preparing for future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.